• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL¿ PROTECTOR P14; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL¿ PROTECTOR P14; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 515100
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/24/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that the bd phaseal¿ protector p14 experienced leakage.The following information was provided by the initial reporter: customer continues to have issues with p-14 protectors not operating correctly.Sometimes chemo leaks from the deice.
 
Additional Manufacturer Narrative
Investigation summary: no photos or physical samples that display the reported condition were available for investigation.A device history review was performed for lot 2201139, no deviations or non-conformances were identified during the manufacturing process that could have contributed to the reported issue.Five retained samples of the same lot were used for additional evaluation.The product was visually inspected, no damage or defects were observed.Functional testing was performed, connecting the protectors to a vial using the m12 assembly fixture, then to an injector and syringe per the instructions for use provided with the product.In all cases liquid was able to be drawn from the vial, the expansion chamber properly expanded, no leakage into the expansion chamber or between the protector and vial was observed, and the product functioned as intended.Product undergoes a series of testing during manufacturing to ensure the quality and functionality of the device.These tests include visual inspections along with leakage testing, flow rate, and verification of the proper placement and function of the expansion chamber.All records were reviewed for the reported lot and results were found to be acceptable.Based on the available information we are not able to determine a root cause at this time.H3 other text : see h10.
 
Event or Problem Description
It was reported that the bd phaseal¿ protector p14 experienced leakage.The following information was provided by the initial reporter: customer continues to have issues with p-14 protectors not operating correctly.Sometimes chemo leaks from the deice.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL¿ PROTECTOR P14
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer (Section G)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15118022
Report Number3003152976-2022-00335
Device Sequence Number7329417
Product Code ONB
UDI-Device Identifier00382905151002
UDI-Public00382905151002
Combination Product (Y/N)N
Initial Reporter StateSC
Initial Reporter CountryUS
PMA/510(K) Number
K123213
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number515100
Device Lot Number2201139
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/27/2022
Supplement Date Received by Manufacturer09/27/2022
Initial Report FDA Received Date07/27/2022
Supplement Report FDA Received Date10/06/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/03/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-